Agilent Technologies Obtains Multicolor, CGH Microarray Licenses from Abbott Molecular
Agilent Technologies Inc. announced it has obtained worldwide, non-exclusive patent licenses from Abbott Molecular Inc. for the manufacture, marketing and sale of oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization (CGH) applications.
This license covers microarray applications, including research, commercial laboratories and in vitro diagnostics. Expressly built into the grant of rights are related products, instruments, components and services. Details of the licensing agreement were not disclosed.
Most read news
Organizations
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.